wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35906506-026EDD41-7304-44FD-95EB-824A609E42CB
Q35906506-026EDD41-7304-44FD-95EB-824A609E42CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906506-026EDD41-7304-44FD-95EB-824A609E42CB
Optimizing the Care of Patients With Type 2 Diabetes Using Incretin-Based Therapy: Focus on GLP-1 Receptor Agonists.
P2860
Q35906506-026EDD41-7304-44FD-95EB-824A609E42CB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35906506-026EDD41-7304-44FD-95EB-824A609E42CB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0cbb3090ea628c05298efa2843451d0576fd220
P2860
Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes.